Q3 2013

Filed Nov 5, 2013 · 10-Q · 36 days after period end · 0001193125-13-427929

Q3 2013 · 10-Q

Revenue—

Net Income

-$7.19M

N/M vs Q3 2012

EPS Diluted

-$0.17

N/M vs Q3 2012

Operating Cash Flowderived-$6,002,092N/M

Free Cash Flow

Same quarter

Metric	Q3 2013	Q3 2012	Q3 2011	Q3 2010
Revenue	—	$264.00K	$223.59K	$253.52K
Net Income	-$7.19M	-$16.34M	-$4.33M	-$5.55M
EPS Diluted	-$0.17	-$0.54	-$0.31	-$0.44

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Microbot Medical Inc. · CIK 883975 · Engraved from SEC EDGAR